Search

Your search keyword '"Wedemeyer, Heiner"' showing total 1,991 results

Search Constraints

Start Over You searched for: Author "Wedemeyer, Heiner" Remove constraint Author: "Wedemeyer, Heiner" Language english Remove constraint Language: english
1,991 results on '"Wedemeyer, Heiner"'

Search Results

11. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis

13. Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis

15. Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity

18. HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx

19. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial

23. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta

24. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

32. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis—a study protocol for a multicenter, randomized, controlled parallel group trial

34. HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication

35. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

38. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

39. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

40. A global research priority agenda to advance public health responses to fatty liver disease

41. No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta

42. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study

47. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Catalog

Books, media, physical & digital resources